In addition, the nuclear expression of p53 or beta‐catenin also showed an inverse correlation with altered ARID1A expression, demonstrating that inactivated ARID1A accelerates HCC growth through a pathway that is different from the p53 and beta‐catenin pathways. This evidence concerns the gene ARID1A and hepatocellular carcinoma.